Phase I trial of vandetanib and oral etoposide (VP-16) for recurrent malignant gliomas (MG).

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Brickhouse, A; Vredenburgh, JJ; Gururangan, S; Reardon, DA; Desjardins, A; Peters, K; Herndon, JE; Norfleet, J; Marcello, J; Friedman, HS

Published Date

  • May 20, 2010

Published In

Volume / Issue

  • 28 / 15_suppl

Start / End Page

  • 2038 - 2038

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2010.28.15_suppl.2038

Language

  • en